Centrum für Integrierte Onkologie (CIO)

What Centrum für Integrierte Onkologie (CIO) does

Centrum für Integrierte Onkologie (CIO) is a collaborative network of four German university cancer centers located in Aachen, Bonn, Cologne, and Düsseldorf, formalized in 2018 to integrate oncology care, research, and clinical trial infrastructure across the four hospital campuses. The network operates more than 40 Interdisciplinary Oncology Programs (IOPs) covering 27+ cancer types — including acute leukemias, breast cancer, colorectal cancer, lung cancer, brain tumors, and rare entities — and runs a centralized clinical trials registry with over 400 active oncology studies per year. Core technology and clinical capabilities include molecular tumor diagnostics (Molekulare Tumordiagnostik), CAR-T cell therapy (including a first-in-Germany fully outpatient CAR-T program), a shared cancer registry and biobank, the Health Services Research Network, and the Kimona research collaboration. The network is certified as an 'Onkologisches Spitzenzentrum' (Oncological Center of Excellence) by Deutsche Krebshilfe.

CIO is not a commercial revenue entity; it functions as a coordination and governance layer for the four state-owned university hospitals. Services are reimbursed through the German statutory (GKV) and private (PKV) health insurance systems at the individual hospital level, with no separately disclosed CIO pricing or revenue. The go-to-market is referral-based: community physicians and non-university hospitals direct complex oncology cases into CIO via a formal Zuweiser (referrer) portal, supplemented by the CIO-Satellitenmodell, which extends specialty expertise to partner regional hospitals. Additional channels include Patiententag ABCD (online patient education events), a video library, and CIO Connect physician education events. Customer segments are limited to cancer patients in Germany requiring specialized multidisciplinary care, with no enterprise or B2B customer base. The coordinating office operates with 9 employees and no disclosed funding, parent company, or ownership structure beyond the four-member governance framework.

Name

Centrum für Integrierte Onkologie (CIO)

Legal name

Centrum für Integrierte Onkologie

Website

https://cio-koeln-bonn.de

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Centrum für Integrierte Onkologie (CIO) is a collaborative network of four German university cancer centers (Aachen, Bonn, Cologne, Düsseldorf) that delivers integrated oncology diagnosis, treatment, and clinical trials across 27+ cancer types. It serves cancer patients in Germany through referral-based university hospital care and is certified as a Deutsche Krebshilfe Oncological Center of Excellence.

Ownership category

akta.pro rank

Product category

Specialty Oncology Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industry

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Integrated oncology care
• Cancer treatment services
• Clinical oncology research
• University cancer centers
• Oncology clinical trials

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Reimbursement: CIO provides oncology healthcare services reimbursed through the German statutory (GKV) and private (PKV) health insurance systems. As a university hospital network, services include inpatient and outpatient care, diagnostics, and treatments.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Centrum für Integrierte Onkologie (CIO) is a collaborative network of four German university cancer centers in Aachen, Bonn, Cologne, and Düsseldorf, founded in 2018. The organization delivers integrated cancer diagnosis, treatment, and clinical research services across 27+ cancer types, supported by 40+ Interdisciplinary Oncology Programs (IOPs) and more than 400 clinical trials per year. CIO is certified as an 'Onkologisches Spitzenzentrum' (Oncological Center of Excellence) by Deutsche Krebshilfe and offers supportive care including psycho-oncology, palliative medicine, and nutritional counseling.

Product overview

CIO (Centrum für Integrierte Onkologie) is a network of four university cancer centers in Aachen, Bonn, Cologne (Köln), and Düsseldorf that functions as a comprehensive oncology center-of-excellence designated by Deutsche Krebshilfe. The organization provides integrated cancer care through specialized treatment centers and 40+ Interdisciplinary Oncology Programs (IOPs) covering 27+ cancer types, supported by over 400 annual clinical trials. The portfolio includes core treatment services, research infrastructure (pathology, biobank, Health Services Research Network, Kimona), patient education (Patiententag ABCD with video library), supportive care (psycho-oncology, palliative medicine, nutrition, exercise), and professional physician education (CIO Connect). The four university hospitals collaborate since 2018 to pool expertise and provide comprehensive oncology services.

Differentiator

Problem solved

Functional benefit

Products and services

• Krebsbehandlung (Cancer Treatment) Integrated cancer treatment services covering acute leukemias, breast cancer, colorectal cancer, lung cancer, brain tumors, and other cancer types, delivered through four collaborating university hospitals for individual cancer patients.
• IOPs (Interdisziplinäre Onkologische Programme) Interdisciplinary Oncology Programs providing specialized treatment protocols and coordinated multidisciplinary care for specific cancer types such as breast cancer, colorectal cancer, pancreatic cancer, leukemia, and cell therapy.
• Klinische Studien (Clinical Trials) More than 400 clinical trials per year covering oncological indications, managed through a centralized clinical trials registry accessible to patients and physicians across the four university hospitals.
• Psychoonkologie und Palliativmedizin (Psycho-Oncology and Palliative Care) Supportive care services for cancer patients including psycho-oncology, palliative medicine, nutritional counseling, exercise programs, complementary medicine, and self-help groups.
• Forschungsinfrastruktur (Research Infrastructure) Joint research programs including pathology, biobank, Health Services Research Network, and Kimona network enabling integrated cancer research collaboration across the four university hospitals.

Quantifiable outcome

• Over 400 clinical trials conducted annually

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Universitätsklinikum Düsseldorf (UKD)coreStrategic or Co-development PartnerOne of four founding university hospitals in the CIO network. Provides comprehensive oncology services including diagnostics, treatment, and clinical trials. Collaborates with other CIO members on shared research programs and patient care protocols.
• Universitätsklinikum Köln (UK Köln)coreStrategic or Co-development PartnerOne of four founding university hospitals in the CIO network. Provides comprehensive oncology services including diagnostics, treatment, and clinical trials. Collaborates with other CIO members on shared research programs and patient care protocols.
• Universitätsklinikum Bonn (UKB)coreStrategic or Co-development PartnerOne of four founding university hospitals in the CIO network. Provides comprehensive oncology services including diagnostics, treatment, and clinical trials. Collaborates with other CIO members on shared research programs and patient care protocols.
• Universitätsklinikum RWTH Aachen (UKAachen)coreStrategic or Co-development PartnerOne of four founding university hospitals in the CIO network. Provides comprehensive oncology services including diagnostics, treatment, and clinical trials. Collaborates with other CIO members on shared research programs and patient care protocols.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Charité Comprehensive Cancer Center: Comprehensive Cancer Center at Charité — Universitätsmedizin Berlin, a Deutsche Krebshilfe-certified Spitzenzentrum with similar interdisciplinary oncology programs, clinical trials, and CAR-T capability serving the Berlin/Northeast catchment.
• University Cancer Center Hamburg (UCCH): Comprehensive Cancer Center at University Medical Center Hamburg-Eppendorf, certified Spitzenzentrum. Comparable in providing university-based integrated oncology care, early-phase trials, and translational research infrastructure.
• Comprehensive Cancer Center Vienna: Comprehensive Cancer Center at Medical University of Vienna, offering interdisciplinary oncology programs, clinical trials, and CAR-T capability — a comparable DACH-region academic oncology network with a similar Spitzenzentrum-equivalent profile.
• Vall d'Hebron Institute of Oncology (VHIO): Research-intensive oncology institute embedded within Vall d'Hebron University Hospital in Barcelona. Comparable in translational research focus, early-phase trial activity, and academic medical-center integration.
• Nationales Centrum für Tumorerkrankungen (NCT Heidelberg): Germany's flagship oncology center of excellence jointly run by DKFZ and Heidelberg University Hospital. NCT is the most prominent German Spitzenzentrum and competes with CIO for complex oncology referrals, CAR-T programs, and industry-sponsored trials.
• Comprehensive Cancer Center München (CCC München): Joint oncology center of TUM and LMU university hospitals in Munich, certified Spitzenzentrum. Comparable in offering IOP-style interdisciplinary programs, molecular tumor boards, and a high-volume clinical trials portfolio.
• Westdeutsches Tumorzentrum (WTZ): Network of university cancer centers in Essen and Münster, also Deutsche Krebshilfe-certified. WTZ overlaps CIO's North Rhine-Westphalia catchment and competes directly for regional oncology referrals and trial enrollment.

Broad incumbents

• Princess Margaret Cancer Centre: One of the world's largest academic cancer centers, affiliated with the University of Toronto. Comparable in offering integrated oncology care, advanced therapy programs, and a high-volume clinical trials portfolio across all major cancer types.
• Gustave Roussy Cancer Campus: Europe's largest dedicated cancer center, located near Paris. Broader incumbent with overlapping capabilities in molecular oncology, cell therapy, and clinical trials across all major cancer types, serving as a pan-European benchmark.

Others

• Deutsches Krebsforschungszentrum (DKFZ): Germany's national cancer research center and co-operator of NCT Heidelberg. DKFZ is a research partner/ecosystem participant rather than a direct clinical competitor — comparable through shared translational research programs and biobanking initiatives.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/centrum-f%C3%BCr-integrierte-onkologie-cio-

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum für Integrierte Onkologie (CIO)